Valuation : Repligen Corporation

Market Cap 9.32B 8.03B 7.61B 6.89B 12.93B 891B 13B 90.32B 34.73B 453B 35.01B 34.24B 1,432B P/E 2026 *
219x
P/E 2027 * 95.6x
Enterprise Value 9.06B 7.8B 7.39B 6.7B 12.56B 865B 12.63B 87.76B 33.75B 440B 34.02B 33.27B 1,391B EV / Sales 2026 *
11x
EV / Sales 2027 * 9.12x
Free-Float
94.31%
Yield 2026 *
-
Yield 2027 * -
1 day+0.30%
1 week-1.44%
Current month-8.73%
1 month+0.25%
3 months+23.89%
6 months+38.54%
Current year+0.81%
1 week 161.14
Extreme 161.1416
172.94
1 month 161.14
Extreme 161.1416
188.73
Current year 100.99
Extreme 100.99
188.73
1 year 100.99
Extreme 100.99
188.73
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Sell

Chief Executive Officer

-3,035 0.0054%
01/09/26 Tax

Controller/Auditor

-277 0.0005%
20/08/26 Exercice

Chief Executive Officer

16,278 0.0288%
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%-1.44%+38.21%+1.30% 9.32B
-1.36%-5.89%-23.14%-0.49% 176B
-0.72%-3.41%-3.49%+11.74% 116B
+0.19%-2.83%+6.20%+80.93% 61.36B
-1.92%-6.01%+8.80%+41.11% 49.42B
+0.81%-3.73%-6.67%-33.43% 48.44B
-1.75%-5.54%+9.25%-22.61% 31.33B
+0.43%-11.10% - - 28.56B
+0.58%+1.84%+31.28%-12.82% 24.37B
+0.49%-7.65%-12.44%+4.86% 21.57B
Average -0.29%-4.72%+5.33%+7.84% 56.71B
Weighted average by Cap. -0.67%-4.84%-5.30%+10.68%

Financials

2026 *2027 *
Net sales 827M 712M 675M 611M 1.15B 79B 1.15B 8.01B 3.08B 40.19B 3.11B 3.04B 127B 974M 840M 795M 721M 1.35B 93.09B 1.36B 9.44B 3.63B 47.36B 3.66B 3.58B 150B
Net income 41.92M 36.12M 34.2M 31M 58.16M 4.01B 58.45M 406M 156M 2.04B 157M 154M 6.44B 98.84M 85.16M 80.64M 73.09M 137M 9.44B 138M 958M 368M 4.8B 371M 363M 15.18B
Net Debt -265M -228M -216M -196M -367M -25.3B -369M -2.57B -987M -12.87B -995M -973M -40.68B -438M -377M -357M -324M -608M -41.85B -611M -4.24B -1.63B -21.29B -1.65B -1.61B -67.27B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
11/09/26 $165.18 +0.30% 944,558
10/09/26 $164.68 -0.22% 955,980
09/09/26 $165.05 -2.06% 1,081,203
08/09/26 $168.53 +0.55% 779,443
04/09/26 $167.60 -1.19% 806,066
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
165.18USD
Average target price
189.48USD
Spread / Average Target
+14.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!